Doping Control Using High and Ultra-High Resolution Mass Spectrometry Based Non-Targeted Metabolomics-A Case Study of Salbutamol and Budesonide Abuse

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Kiss, Agneta ^a   Lucio, Marianna ^b   Fildier, Aurélie ^a   Buisson, Corinne ^c   Schmitt Kopplin, Philippe ^b,d   Cren Olivé, Cécile ^a  

^a Institut des Sciences Analytiques   (France)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Agence Française de Lutte contre le Dopage AFLD   (France)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; GLUCOCORTICOID; SALBUTAMOL;

ARTICLE; ATHLETE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPING; DRUG DEPENDENCE; ELECTROSPRAY; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MASS SPECTROMETRY; METABOLOMICS; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; ULTRA HIGH RESOLUTION MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

ALBUTEROL; ATHLETES; BUDESONIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATINE; CYCLOTRONS; DOPING IN SPORTS; FOURIER ANALYSIS; HEALTHY VOLUNTEERS; HUMANS; LEAST-SQUARES ANALYSIS; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; RIBONUCLEOSIDES; SIGNAL PROCESSING, COMPUTER-ASSISTED; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84884242123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074584     Document Type: Article

References (41)

1. Kanehisa M, Goto S, (2000) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28: 27-30. doi:10.1093/nar/28.7.e27. PubMed: 10592173.
2. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M, (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40: D109-D114. doi:10.1093/nar/gkr988. PubMed: 22080510.
3. Wishart DS, Knox C, Guo AC, Eisner R, Young N, et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37(Database issue): D603-10. PubMed: 18953024.
4. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, et al. (2007) HMDB: the Human Metabolome Database. Nucleic Acids Res 35(Database issue):D521-6. PubMed: 17202168.
5. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, et al. (2007) HMDB: the Human Metabolome Database. Nucleic Acids Res 35: D521-D526. doi:10.1093/nar/gkl923. PubMed: 17202168.
6. Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, et al. (2010) Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 9: 2424-2437. doi:10.1074/mcp.M110.001917. PubMed: 20616184.
7. Suhre K, Schmitt-Kopplin P, (2008) MassTRIX: mass translator into pathways. Nucleic Acids Res 36: W481-W484. doi:10.1093/nar/gkn194. PubMed: 18442993.
8. Wägele B, Witting M, Schmitt-Kopplin P, Suhre K, (2012) MassTRIX Reloaded: Combined Analysis and Visualization of Transcriptome and Metabolome Data. PLOS ONE 7: e39860. doi:10.1371/journal.pone.0039860. PubMed: 22815716.
9. Fonville JM, Richards SE, Barton RH, Boulange CL, Ebbels TMD, (2010) The evolution of partial least squares models and related chemometric approaches in metabonomics and metabolic phenotyping. J Chemom, 24: 636-649. doi:10.1002/cem.1359.
10. Trygg J, Holmes E, Lundstedt T, (2007) Chemometrics in metabonomics. J Proteome Res 6: 469-479. doi:10.1021/pr060594q. PubMed: 17269704.
11. Waterman DS, Bonner FW, Lindon JC, (2009) Spectroscopic and statistical methods in metabonomics. Bioanalysis 1: 1559-1578. doi:10.4155/bio.09.143. PubMed: 21083104.
12. Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, et al. (2009) Metabolomics reveals metabolic biomarkers of Crohn's disease. PLOS ONE 4(7):: e6386. doi:10.1371/journal.pone.0006386. PubMed: 19636438.
13. Xu EY, Schaefer WH, Xu Q, (2009) Metabolomics in pharmaceutical research and development: Metabolites, mechanisms and pathways. Curr Opin Drug Discov Devel 12: 40-52. PubMed: 19152212.
14. Wishart DS, (2008) Applications of metabolomics in drug discovery and development. Drugs R D 9: 307-322. doi:10.2165/00126839-200809050-00002. PubMed: 18721000.
15. McNiven EM, German JB, Slupsky CM, (2011) Analytical metabolomics: nutritional opportunities for personalized health. J Nutr Biochem 22: 995-1002. doi:10.1016/j.jnutbio.2011.05.016. PubMed: 21999844.
16. Manach C, Hubert J, Llorach R, Scalbert A, (2009) The complex links between dietary phytochemicals and human health deciphered by Metabolomics. Mol Nutr Food Res 53: 1303-1315. doi:10.1002/mnfr.200800516. PubMed: 19764066.
17. Roux A, Lison D, Junot C, Heilier JF, (2011) Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review. Clin Biochem 44: 119-135. doi:10.1016/j.clinbiochem.2011.08.1091. PubMed: 20800591.
18. Nordström A, Lewensohn R, (2010) Metabolomics: Moving to the Clinic. J Neuroimmune Pharmacol 5: 4-17. doi:10.1007/s11481-009-9156-4. PubMed: 19399626.
19. Zhang J, Yan L, Tian M, Huang Q, Peng S, et al. (2012) The metabonomics of combined dietary exposure to phthalates and polychlorinated biphenyls in mice. J Pharm Biomed Anal 66: 287-297. doi:10.1016/j.jpba.2012.03.045. PubMed: 22502909.
20. Kiss A, Jacquet AL, Paisse O, Flament-Waton MM, de Ceaurriz J, et al. (2011) Urinary signature of anabolic steroids and glucocorticoids in humans by LC-MS. Talanta 83: 1769-1773. doi:10.1016/j.talanta.2010.10.030. PubMed: 21238782.
21. Boyard-Kieken F, Dervilly-Pinel G, Garcia P, Paris AC, Popot MA, et al. (2011) Comparison of different liquid chromatography stationary phases in LC-HRMS metabolomics for the detection of recombinant growth hormone doping control. J Sep Sci 34: 3493-3501. doi:10.1002/jssc.201100223. PubMed: 21710695.
22. Badoud F, Guillarme D, Boccard J, Grata E, Saugy M, et al. (2011) Analytical aspects in doping control: Challenges and perspectives. Forensic Sci Int 213: 49-61. doi:10.1016/j.forsciint.2011.07.024. PubMed: 21824736.
23. Anizan S, Bichon E, Duval T, Monteau F, Cesbron N, et al. (2012) Gas chromatography coupled to mass spectrometry-based metabolomic to screen for anabolic practices in cattle: identification of 5α-androst-2-en-17-one as new biomarker of 4-androstenedione misuse J Mass Spectrom 47: 131-40.
24. World Anti-Doping Agency website. Available: http://www.wada-ama.org. Accessed 2013 September 6.
25. Bryan J, (2007) Ventolin remains a breath of fresh air for asthma sufferers, after 40 years. Pharm J 279: 404-405.
26. Ventura R, Segura J, Bergés R, Fitch KD, Morton AR, et al. (2000) Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control. Ther Drug Monit 22: 277-282. doi:10.1097/00007691-200006000-00008. PubMed: 10850394.
27. Deventer K, Mikulcíková P, Van Hoecke H, Van Eenoo P, Delbeke FT, et al. (2006) Detection of budesonide in human urine after inhalation by liquid chromatography-mass spectrometry. J Pharm Biomed Anal 42: 474-479. doi:10.1016/j.jpba.2006.05.016. PubMed: 16842962.
28. Gika HG, Macpherson E, Theodoridis GA, Wilson ID, (2008) Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 871: 299-305. doi:10.1016/j.jchromb.2008.05.048. PubMed: 18579458.
29. Gika HG, Theodoridis GA, Wilson ID, (2008) Liquid chromatography and ultraperformance liquid chromatography-mass spectrometry fingerprinting of human urine- Sample stability under different handling and storage conditions for metabonomics studies. J Chromatogr A 1182: 314-322.
30. Sangster T, Major H, Plumb R, Wilson AJ, Wilson ID, et al. (2006) A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst 131: 1075-1078. doi:10.1039/b604498k. PubMed: 17003852.
31. Lucio M, Fekete A, Schmitt-Kopplin P, (2010) High resolution tools offer to follow bacterial growth on a molecular level In: Handbook of Molecular Microbial Ecology I Metagenomics and Complementary Approaches. Hoboken: Wiley-Blackwell.
32. Lucio M, Fekete A, Weigert C, Wägele B, Zhao X, et al. (2010) Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach. PLOS ONE 5(10):: e13317. doi:10.1371/journal.pone.0013317. PubMed: 20976215.
33. Kohler M, Walpurgis K, Thomas A, de Maree M, Mester J, et al. (2010) Effects of endurance exercise on the urinary proteome analyzed by 2-D PAGE and Orbitrap MS. Proteomics Clin Appl 4: 568-576. PubMed: 21137074.
34. Yan B, J A, Wang GJ, Lu HL, Huang XP, et al. (2009) Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training. J Appl Physiol 106: 531-538. PubMed: 19036890.
35. Burns SF, Oo HH, Tran AT, (2012) Effect of Sprint Interval Exercise on Postexercise Metabolism and Blood Pressure in Adolescents. Int J Sport Nutr Exerc Metab 22: 47-54. PubMed: 22248500.
36. Broad EM, Maughan RJ, Galloway S DR, (2011) Effects of Exercise Intensity and Altered Substrate Availability on Cardiovascular and Metabolic Responses to Exercise After Oral Carnitine Supplementation in Athletes. Int J Sport Nutr Exerc Metab 21: 385-397. PubMed: 21813919.
37. Paetsch PR, Greenshaw AJ, (1991) Beta-Adrenergic Effects On Plasma And Brain Large Neutral Amino-Acids Are Unaltered by Chronic Administration of Antidepressants. J Neurochem 56: 2027-2032.
38. del Barrio AS, García-Calonge MA, Fernández-Quintela A, Simón E, Portillo MP, et al. (1995) Effects of the Beta-Adrenergic Agonist Salbutamol and Its Withdrawal on Protein-Metabolism Of Lambs Ann Nutr Metab 39: 317-324. doi:10.1159/000177879. PubMed: 8585702.
39. Bastos ML, Carvalho F, Remião F, Mendes ME, Ferreira MA, et al. (1997) Changes in taurine levels in response to repeated administration of the beta 2-agonist salbutamol in lambs. J Vet Pharmacol Ther 20: 33-37. doi:10.1046/j.1365-2885.1997.00046.x. PubMed: 9049947.
40. Martineau L, Horan MA, Rothwell NJ, Little RA, (1992) Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci 83: 615-621. PubMed: 1335400.
41. van Baak MA, Mayer LH, Kempinski RE, Hartgens F, (2000) Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Med Sci Sports Exerc 32: 1300-1306. doi:10.1097/00005768-200007000-00018. PubMed: 10912897.